This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) shed 6.43% to $131.30 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 5.16% to 11,633.57 and Dow Jones Industrial Average falling 3.94% to 31,104.97. This was the stock's second consecutive day of losses. Moderna Inc. closed $327.20 below its 52-week high ($458.50), which the company achieved on September 23rd.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. (ABBV) fell 2.61% to $138.53, Amgen Inc. (AMGN) fell 4.53% to $226.86, and AstraZeneca PLC ADR (AZN.LN) fell 4.47% to $58.99. Trading volume (4.9 M) eclipsed its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 13, 2022.
(END) Dow Jones Newswires
September 13, 2022 16:31 ET (20:31 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.